Global leader in genomics, Illumina has partnered with world-class academic institution, the University of Melbourne to establish The Advanced Genomics Collaboration (TAGC), formerly known as the Illumina–University of Melbourne Genomics Hub.
In partnership with the Victorian Government, Israeli-founded Data Science Group (DSG) marks its arrival in Australia by establishing its Artificial Intelligence (AI) Centre of Excellence (CoE) in Melbourne.
Bukalapak, one of Indonesia’s largest all-commerce companies, has chosen Melbourne’s thriving tech sector as its first international base to establish a research and development centre.
Victoria welcomes the arrival of the Suiso Frontier, the world’s first purpose-built liquefied hydrogen carrier, which marks the success of the Hydrogen Energy Supply Chain (HESC) pilot project.
German consulting firm, TNG Technology Consulting (TNG) has established its Australian base in Melbourne.
Digital transformation company, Onepoint has chosen Melbourne to establish its APAC TechHub in Melbourne to service its growing client base across Asia and Australia.
Australia’s leading tech city has secured significant international tech conferences bringing together global blockchain experts and tech players right here to Melbourne.
A global hub for biopharma manufacturing, Melbourne has been chosen as the home of Moderna’s first mRNA manufacturing facility outside of North America, following an in principle agreement with the Commonwealth and Victorian Governments.
On a mission to accelerate the world's transition to cryptocurrency, Crypto.com has chosen to establish its Australian headquarters in Melbourne, the nation’s leading tech city.
mRNA research in Victoria will benefit from a funding boost that will fast-track sovereign manufacturing and health-care breakthroughs.
Two new Commissioners for Victoria to the Americas have commenced in their roles to facilitate investment and trade opportunities between the two regions.
Clinical trials for Australia’s first ever mRNA drug product are set to begin next year, following the successful creation of Australia’s first mRNA COVID-19 vaccine candidate.